68462-329Level 3
Trandolapril and Verapamil Hydrochloride (Trandolapril and Verapamil Hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
**Strength:** 4; 240 mg/1; mg/1
**Dosage form:** Tablet, Film Coated, Extended Release
**Route:** Oral
**Labeler:** Glenmark Pharmaceuticals Inc., USA
**Marketing category:** ANDA (ANDA079135)
**Pharmacologic class:** Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/68462-329Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.